WALTHAM, Mass., June 18, 2020 (GLOBE NEWSWIRE) — Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on […]
Company expects to generate positive cash flows from operating activities, positive Free Cash Flow, and further strengthen liquidity position during […]